Separate names with a comma.
Discussion in 'Sunovion' started by anonymous, Feb 1, 2018 at 6:51 PM.
in 9 months of selling inhaler portfolio, 3 million $ This may be under target
It’s a real shocker Novartis parted with these 11th to market game changers...
Litterally just curious, do you know how they plan to market Lonhala? How is it going?
don't worry Timmy's got it....bahhahahahahahahahahahahaha
Ugh ya think? this cant last
